Despite the low prevalence of aggressive or extensive cancer missed by MR imaging, close follow-up examination of PSA should be necessary in patients with negative MR results if MR imaging with ADC maps can be used for the screening of patients for subsequent prostate biopsies. Here, KLK3 is linked to cancer.